ROBA PHARMA
ActiveSummary
ROBA PHARMA has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €311,875 and a net result of €3,538. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 92% of 784 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 30-10-2018 Normal situation
- Activity
- Manufacture of medical and dental instruments and supplies NACE 32500and 1 other
- Establishment unit
- 2.284.090.771 8500 Kortrijk, since 30-10-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 09-02-2026
Board and ownership
- Vialma Invest BVDirector · since 30-10-2018
- Holdings
- Shares in 1 company Roba Pharma NL
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €38,070
- ▼ 88.2%
- Turnover
- ≈ €150,000
- estimated
- Profit
- €3,538
- ▼ 98.6%
- Equity
- €311,875
- ▲ 1.1%
- Total assets
- €352,134
- ▼ 71.3%
Score breakdownraises riskFounded in 2018lowers riskEquity €311,875 (88.6% of total assets)Figures for financial year 2025 (filed on 15-07-2026)Sector: Other manufacturing (NACE 32)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 90% of them on solvency, 59% on liquidity, 21% on profitability and 44% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed 1 director appointed, 1 director resigningResignation: NV Balansa (director) · Permanent representatives: Ludwig GELDOF and Hanne DEWULF · Appointment: Vincent DEMEYERE (medebestuurder)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as ROBA PHARMA: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €201,000 and €411,000, founded between 2012 and 2019.
| Company | Total assets | Gross margin |
|---|---|---|
| ROBA PHARMA Kortrijk | €352,134 | €38,070 |
| DJS OPTIQUE Brussel | €276,584 | €43,715 |
| FIGO OPTICS Maaseik | €283,207 | €62,105 |
| ESTHEL Ieper | €410,978 | €47,151 |
| MR4OF Sint-Gillis (bij-Brussel) | €410,403 | €56,358 |
| REVATEC Seraing | €329,121 | €66,088 |
| OrthoFlex Ternat | €201,408 | €45,040 |
Key facts about ROBA PHARMA
- What is the company number of ROBA PHARMA?
- The company number of ROBA PHARMA is 0712.710.765. The VAT number is the same number with BE in front: BE 0712.710.765.
- Where is ROBA PHARMA based?
- The registered office is at Ruitersweg(Kor) 3, 8500 Kortrijk.Company details
- What does ROBA PHARMA do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of ROBA PHARMA?
- The legal form of ROBA PHARMA is Private limited company (BV).
- When was ROBA PHARMA founded?
- ROBA PHARMA was founded on 30-10-2018.
- Is ROBA PHARMA still active?
- Yes, ROBA PHARMA is an active enterprise in the KBO register.
- What is the turnover of ROBA PHARMA?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €38,070 and 2,954 comparable companies of the same size. It probably lies between €92,000 and €280,000. It is a rough estimate.Financials
- Is ROBA PHARMA profitable?
- In financial year 2025, ROBA PHARMA made a profit of €3,538.
- Where can I find the annual accounts of ROBA PHARMA?
- ROBA PHARMA filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ROBA PHARMA due?
- ROBA PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.